Department of Psychology and Neuroscience, Dalhousie University, Halifax, Nova Scotia, Canada.
Brain Repair Center, Halifax, Nova Scotia, Canada.
Cannabis Cannabinoid Res. 2024 Aug;9(4):1006-1014. doi: 10.1089/can.2022.0326. Epub 2023 Aug 7.
Cannabidiol (CBD), a nonpsychoactive cannabinoid found in the cannabis plant, has gained interest for its purported stress- and anxiety-reducing effects. However, the mechanisms underlying these effects remain unclear. Our group previously found that CBD expectancy alone resulted in lower state anxiety (vs. CBD-free expectancy) among those who strongly believed it was helpful for such purposes, in addition to influencing physiological measures (i.e., heart rate variability). Using data collected as part of this previously published larger study, we aimed to explore the extent to which CBD expectancy alone impacts cortisol in the context of a laboratory stressor. A sample of 43 healthy adults (23 female) participated in one orientation and two experimental laboratory sessions. They received the same oil (CBD-free) during both experimental sessions but were told they received CBD oil in counterbalanced order in one of their sessions. Participants then engaged in a laboratory stressor (the Maastricht Acute Stress Test; MAST) and salivary cortisol samples were collected throughout [T1: baseline; T2: 90-min postabsorption (PA); T3: poststress (0-PS); T4: 10-min poststress (10-PS); T5: 30-min poststress (30-PS)]. Linear marginal models were used for analyses. Findings indicated that a physiological stress response was elicited in the context of the MAST, which is consistent with what has been reported previously. Interestingly, while cortisol levels were significantly lower in the CBD expectancy condition (vs. CBD-free) immediately following the MAST (0-PS) and 10-min later (10-PS), this effect seems to be largely driven by males, evidenced by a three-way interaction. Cortisol levels did not reliably vary across expectancy conditions at any other time point. Overall, these results suggest that CBD expectancy appears to blunt cortisol in anticipation of a stressor, particularly in males. Findings suggest that it is important to consider the impact of drug-related expectations when assessing CBD-related effects on stress-related processes.
大麻二酚(CBD)是一种存在于大麻植物中的非精神活性大麻素,因其据称具有减轻压力和焦虑的作用而受到关注。然而,这些作用的机制尚不清楚。我们的研究小组之前发现,仅 CBD 预期就会导致那些强烈认为 CBD 对缓解此类压力和焦虑有帮助的人(与影响生理指标,如心率变异性)的状态焦虑降低。使用之前发表的更大研究的一部分收集的数据,我们旨在探索在实验室应激源的情况下,仅 CBD 预期对皮质醇的影响程度。 43 名健康成年人(23 名女性)参加了一次定向和两次实验实验室会议。他们在两次实验会议期间都接受了相同的油(CBD 无),但在其中一次会议中以平衡方式告诉他们接受了 CBD 油。然后,参与者进行了实验室应激源(马斯特里赫特急性应激测试;MAST),并在整个过程中采集唾液皮质醇样本 [T1:基线;T2:吸收后 90 分钟(PA);T3:应激后(0-PS);T4:应激后 10 分钟(10-PS);T5:应激后 30 分钟(30-PS)]。线性边缘模型用于分析。 结果表明,在 MAST 的背景下引发了生理应激反应,这与之前的报告一致。有趣的是,虽然在 MAST(0-PS)后和 10 分钟后(10-PS),CBD 预期条件下的皮质醇水平明显低于 CBD 无预期条件,但这种效应似乎主要由男性驱动,这一点由三向交互作用证明。在其他任何时间点,皮质醇水平在预期条件下均未可靠变化。 总体而言,这些结果表明,CBD 预期似乎在应激源出现之前就会使皮质醇水平降低,特别是在男性中。研究结果表明,在评估 CBD 对与压力相关的过程的影响时,考虑与药物相关的预期的影响非常重要。